Send to a Friend Font Size: Increase Decrease

CNTX and BCAB Related Headlines

May 18, 2026 06:45AM Context Therapeutics amends BioAtla license deal for CT-202 drug
May 18, 2026 06:45AM Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202

CNTX and BCAB Related Press Releases

May 18, 2026 06:45AM Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202

CNTX and BCAB Related SEC Filings